摘要:Nicotinamide adenine dinucleotide (NAD
+) is an essential molecule involved in various metabolic reactions, acting as an electron donor in the electron transport chain and as a co-factor for NAD
+-dependent enzymes. In the early 2000s, reports that NAD
+ declines with aging introduced the notion that NAD
+ metabolism is globally and progressively impaired with age. Since then, NAD
+ became an attractive target for potential pharmacological therapies aiming to increase NAD
+ levels to promote vitality and protect against age-related diseases. This review summarizes and discusses a collection of studies that report the levels of NAD
+ with aging in different species (i.e., yeast,
C. elegans, rat, mouse, monkey, and human), to determine whether the notion that overall NAD
+ levels decrease with aging stands true. We find that, despite systematic claims of overall changes in NAD
+ levels with aging, the evidence to support such claims is very limited and often restricted to a single tissue or cell type. This is particularly true in humans, where the development of NAD
+ levels during aging is still poorly characterized. There is a need for much larger, preferably longitudinal, studies to assess how NAD
+ levels develop with aging in various tissues. This will strengthen our conclusions on NAD metabolism during aging and should provide a foundation for better pharmacological targeting of relevant tissues.